NRC - NATIONAL RESEARCH CORP


10.72
0.025   0.233%

Share volume: 75,050
Last Updated: 04-25-2025
Business Services/Services – Research, Development, Testing Labs: -0.08%

PREVIOUS CLOSE
CHG
CHG%

$10.70
0.03
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
79%
Profitability 92%
Dept financing 37%
Liquidity 23%
Performance 91%
Company vs Stock growth
vs
Performance
5 Days
0.28%
1 Month
-23.70%
3 Months
-42.77%
6 Months
-42.89%
1 Year
-68.75%
2 Year
-75.58%
Key data
Stock price
$10.72
P/E Ratio 
16.71
DAY RANGE
$10.24 - $10.91
EPS 
$1.19
52 WEEK RANGE
$9.76 - $35.81
52 WEEK CHANGE
-$68.75
MARKET CAP 
414.117 M
YIELD 
2.72%
SHARES OUTSTANDING 
23.871 M
DIVIDEND
$0.12
EX-DIVIDEND DATE
03-28-2025
NEXT EARNINGS DATE
05-06-2025
BETA 
1.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$77,960
AVERAGE 30 VOLUME 
$92,235
Company detail
CEO: Michael D. Hays
Region: US
Website: nrchealth.com
Employees: 490
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Recent news
loading